ERIS Lifesciences Ltd Half Yearly Results

Gross Sales

1,424.72

1,454.54

1,030.75

960.55

814.43

Excise Duty

0

0

0

0

0

Net Sales

1,424.72

1,454.54

1,030.75

960.55

814.43

Other Operating Income

8.03

6.35

6.48

11.37

11.62

Other Income

12.23

6.19

19.35

4.47

3.24

Total Income

1,444.98

1,467.08

1,056.58

976.39

829.3

Total Expenditure

930.05

946.39

713.29

621.03

569.96

PBIDT

514.93

520.69

343.29

355.36

259.34

Interest

111.45

119.84

51.15

33.65

11.87

PBDT

403.48

400.85

292.14

321.71

247.47

Depreciation

159.04

156.42

99.52

82.99

65.03

Minority Interest Before NP

0

0

0

0

0

Tax

56.25

55.59

35.11

47.11

32.68

Deferred Tax

-0.71

3.07

-23.65

-24.35

-11.95

Reported Profit After Tax

188.9

185.77

181.16

215.96

161.71

Minority Interest After NP

11.83

11

7.39

-2.32

-5.57

Net Profit after Minority Interest

177.07

174.77

173.77

218.29

167.28

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

177.07

174.77

173.77

218.29

167.28

EPS (Unit Curr.)

13

12.84

12.78

16.05

12.3

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

13.62

13.61

13.6

13.6

13.6

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

36.14

35.79

33.3

36.99

31.84

PBDTM(%)

-

-

-

-

-

PATM(%)

13.25

12.77

17.57

22.48

19.85